Results 131 to 140 of about 5,075 (159)

Acyclovir is not effective in pityriasis rosea: Results of a randomized, triple-blind, placebo-controlled trial

, 2016
Sanjay Singh, Narendra Kumar Tiwary
openalex   +1 more source

Pityriasis Rosea Induced by COVID-19 Vaccination. [PDF]

Eur J Case Rep Intern Med, 2022
Khattab E, Christaki E, Pitsios C.
europepmc   +1 more source

Pityriasis rosea along Blaschko's lines: A rare variant

, 2016
Vijay Zawar, Antonio Chuh
openalex   +1 more source

Is a treatment for pityriasis rosea really needed?

, 2016
Giulia Ciccarese, Francesco Drago
openalex   +1 more source

Pityriasis Rosea Eruption Following the Administration of Oxford-AstraZeneca Vaccine. [PDF]

Cureus
Marghalani S, Alghamdi Y, Albrakati BA, Huwait HF, Mohanna AT.   +4 more
europepmc   +1 more source

Pityriasis Rosea after COVID-19 Infection [PDF]

, 2022
Ljubojević Hadžavdić, Suzana, Prtajin, Marta   +1 more
core   +1 more source

Pediatric pityriasis rosea

, 2017
Giulia Ciccarese, Aurora Parodi, Francesco Drago   +2 more
openalex   +1 more source

Challenges in designing studies assessing birth complications and spontaneous abortion in pregnant patients with pityriasis rosea. [PDF]

J Am Acad Dermatol
Ong MM, Lipner SR.
europepmc   +1 more source

AN ANALYTICAL STUDY OF CLINICAL FEATURES IN 100 CASES OF PITYRIASIS ROSEA

, 2017
N. Saravanan, Sindhuja Ramasamy, S Murugan, V. Sridhar, T Vanathi, B Sarathchandran, G P Rekha   +6 more
openalex   +1 more source

A Case of Persistent Pityriasis Rosea Successfully Treated by a Short Course of Therapy with Abrocitinib. [PDF]

Clin Cosmet Investig Dermatol
Wu H, Ji QJ, Xu YY, Zhu JW.
europepmc   +1 more source